|
India News Releases
|
(India.CityRegions.Com, October 26, 2016 ) DelveInsight's, "Biosimilar (Insulin)-Competitive Landscape and Market & Pipeline Analysis, 2016" discusses the global insulin biosimilar industry. Report analyzes that Insulin and Insulin Biosimilars holds a future scope and potential in the market. It highlights the market trends, regulatory requirements for US and EU and key domestic players. Report provides an insight on Insulin Biosimilars that are under development for Type 1 and Type 2 Diabetes with an insight on the Epidemiology of the disease. It provides detailed information on the 11 Insulin Biosimilar that are in pipeline. It analyses Insulin Biosimilar industry and discusses the key market trends, major players, market assessment of 6 marketed insulin and the types of insulin with the length activity available in market. Report provides an update on the recent collaborations occurring in the insulin biosimilar market and the companies looking for partnership for the same. For more information about this report: http://www.reportsweb.com/biosimilar-insulin-competitive-landscape-and-market-and-pipeline-analysis-2016
Report Scope:
-Coverage of global insulin biosimilar under development across the globe -Sales forecast for marketed insulin from 2015 to 2017 -Detailed information on product description and related stage of development, the mode of therapy, mechanism of action, development partner and technology information. -The report discusses the biosimilar regulatory landscape of various markets including developed markets of the US and EU -Report analyses the types of insulin under development with respect to their market share and length of activity
Reason to Buy:
-The insulin biosimilar report covers complete Pipeline intelligence and understanding over therapeutics development for insulin market. -Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage -Identify and understand important and diverse types of insulin under development -Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline -Devise corrective measures for pipeline projects by understanding the insulin biosimilar pipeline in-depth -Identifying the upcoming leaders in the insulin biosimilar market in the coming year
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001153598/sample
Table of contents: Executive Summary Biosimilar History of Insulin and Insulin Biosimilar Development Regulatory Pathways in US and EU Illustration of the Originator and Biosimilar Development Major Indication Epidemology Complications Associated with Diabetes Diagnosis of Diabetes Analysis Clinical Trials Technology Market Assessment Market Trends Drivers Barriers Historical Sales Data for the Marketed Drugs Forecasted Sales Data for the Marketed Drugs Major Competitors Types of insulin and length of activity Pipeline Therapeutics Therapeutics under Development by Companies Therapeutic Assessment Assessment by Monotherapy Products Assessment by Combination Products Assessment by Route of Administration Assessment by Stage and Route of Administration Assessment by Molecule Type Assessment by Stage and Molecule Type Dormant Products Product Development Activities Companies involved in Therapeutics Development
Inquire before Buying at http://www.reportsweb.com/inquiry&RW0001153598/buying
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
|
|
|
India RSS Feed Marketpalce
|
India News Headlines
Daily news from India: arts, business, culture, politics, science, technology & more.
Free Sales & Marketing Magazines
Get free publications about marketing, sales and customer relations management.
Submit RSS feed on India. Have your feed on news, products or services displayed under this marketpalce and have your feed on a full page updated daily.
|
|
India Business News by Major Cities
|
|
|
Listen to GroupWeb Radio
INDIA BUSINESS TV
|